Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis

Expert Review of Cardiovascular Therapy

Volumn 10, Issue 1, 2012, Pages 37-53

  Degnan, Andrew J ^a,b   Young, Victoria E L ^a   Gillard, Jonathan H ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

carotid atherosclerosis; carotid intima media thickness; magnetic resonance imaging; noninvasive imaging; risk prediction; statins; stroke; treatment effect

Indexed keywords

ATORVASTATIN; COLESTIPOL; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG MEGADOSE; ECHOGRAPHY; EVALUATION; HUMAN; IMAGE ANALYSIS; INFLAMMATION; LOW DRUG DOSE; MEASUREMENT; NEOVASCULARIZATION (PATHOLOGY); NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK FACTORS; STROKE;

EID: 83755172714     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.168     Document Type: Review

References (138)

1. Abbott AL, Bladin CF, Levi CR, Chambers BR. What should we do with asymptomatic carotid stenosis? Int. J. Stroke 2(1), 27-39 (2007). (Pubitemid 46195630)
2. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361(9352), 107-116 (2003). (Pubitemid 36092014)
3. Bonifati DM, Lorenzi A, Ermani M et al. Carotid stenosis as predictor of stroke after transient ischemic attacks. J. Neurol. Sci. 303(1-2), 85-89 (2011).
4. Wardlaw JM, Stevenson MD, Chappell F et al. Carotid artery imaging for secondary stroke prevention: both imaging modality and rapid access to imaging are important. Stroke 40(11), 3511-3517 (2009).
5. Wardlaw JM, Chappell FM, Best JJ, Wartolowska K, Berry E; NHS Research and Development Health Technology Assessment Carotid Stenosis Imaging Group. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 367(9521), 1503-1512 (2006).
6. Naylor AR, Gaines PA, Rothwell PM. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur. J. Vasc. Endovasc. Surg. 37(6), 625-632 (2009).
7. Woodward M, Welsh P, Rumley A, Tunstall-Pedoe H, Lowe GD. Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10-year cohort study in Glasgow, Scotland. Eur. Heart J. 31(21), 2669-2675 (2010).
8. Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis - asymptomatic carotid surgery trial. Stroke 35(10), 2425-2427 (2004). (Pubitemid 39311274)
9. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis - results of a systematic review and analysis. Stroke 40(10), E573-E583 (2009).
10. Abbott AL, Donnan GA. Does the 'high risk' patient with asymptomatic carotid stenosis really exist? Eur. J. Vasc. Endovasc. Surg. 35(5), 524-533 (2008). (Pubitemid 351469949)
11. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273(18), 1421-1428 (1995).
12. Woo K, Garg J, Hye RJ, Dilley RB. Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis. Stroke 41(5), 975-979 (2010).
13. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment a prospective, population-based study. Stroke 41(1), E11-E17 (2010).
14. Markus H. Revascularization of asymptomatic high-grade carotid stenosis is still indicated in some cases. Stroke 42(4), 1152-1153 (2011).
15. Goessens BMB, Visseren FLJ, Kappelle LJ, Algra A, Van Der Graaf Y. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease - the SMART study. Stroke 38(5), 1470-1475 (2007). (Pubitemid 46684147)
16. Inzitari D, Eliasziw M, Gates P et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 342(23), 1693-1700 (2000).
17. Korshunov VA, Schwartz SM, Berk BC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon. Arterioscler. Thromb. Vasc. Biol. 27(8), 1722-1728 (2007). (Pubitemid 47207166)
18. Astor BC, Sharrett AR, Coresh J, Chambless LE, Wasserman BA. Remodeling of carotid arteries detected with MR imaging: Atherosclerosis Risk in Communities Carotid MRI study. Radiology 256(3), 879-886 (2010).
19. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96(5), 1432-1437 (1997). (Pubitemid 27375333)
20. De Groot E, Van Leuven SI, Duivenvoorden R et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. 5(5), 280-288 (2008). (Pubitemid 351593910)
21. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J. Hypertens. 20(12), 2317-2325 (2002). (Pubitemid 36026835)
22. Bots ML, Baldassarre D, Simon A et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur. Heart J. 28(4), 398-406 (2007). (Pubitemid 47343565)
23. Mancini GB, Dahlof B, Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 109(25 Suppl. 1), IV22-IV30 (2004).
24. Chambless LE, Heiss G, Shahar E, Earp MJ, Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 160(3), 259-269 (2004). (Pubitemid 39006782)
25. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 30(2), 182-185 (2010).
26. Prati P, Tosetto A, Vanuzzo D et al. Carotid intima-media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke 39(9), 2470-2476 (2008).
27. Del Sol AI, Moons KG, Hollander M et al. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke 32(7), 1532-1538 (2001). (Pubitemid 32631901)
28. Nambi V, Chambless L, Folsom AR et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J. Am. Coll. Cardiol. 55(15), 1600-1607 (2010).
29. Kalogeropoulos A, Terzis G, Chrysanthopoulou A, Hahalis G, Siablis D, Alexopoulos D. Risk for transient ischemic attacks is mainly determined by intima-media thickness and carotid plaque echogenicity. Atherosclerosis 192(1), 190-196 (2007). (Pubitemid 46602297)
30. Mathiesen EB, Johnsen SH. Ultrasonographic measurements of subclinical carotid atherosclerosis in prediction of ischemic stroke. Acta Neurol. Scand. Suppl. (189), 68-72 (2009).
31. Goldberger ZD, Valle JA, Dandekar VK, Chan PS, Ko DT, Nallamothu BK. Are changes in carotid intima-media thicknessrelated to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis. Am. Heart J. 160(4), 701-714 (2010).
32. Yu CM, Zhang Q, Lam L et al. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease. Heart 93(8), 933-939 (2007). (Pubitemid 47122042)
33. Costanzo P, Perrone-Filardi P, Vassallo E et al. Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J. Am. Coll. Cardiol. 56(24), 2006-2020 (2010).
34. Sidhu JS, Kaposzta Z, Markus HS, Kaski JC. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 24(5), 930-934 (2004). (Pubitemid 38620874)
35. Langenfeld MR, Forst T, Hohberg C et al. Pioglitazone decreases carotid intima- media thickness independently of glycemic control in patients with Type 2 diabetes mellitus: results from a controlled randomized study. Circulation 111(19), 2525-2531 (2005). (Pubitemid 40696142)
36. Mazzone T, Meyer PM, Feinstein SB et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in Type 2 diabetes: a randomized trial. JAMA 296(21), 2572-2581 (2006). (Pubitemid 44903861)
37. Minamikawa J, Tanaka S, Yamauchi M, Inoue D, Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in Type 2 diabetes. J. Clin. Endocrinol. Metab. 83(5), 1818-1820 (1998). (Pubitemid 28501066)
38. Koshiyama H, Shimono D, Kuwamura N, Minamikawa J, Nakamura Y. Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in Type 2 diabetes. J. Clin. Endocrinol. Metab. 86(7), 3452-3456 (2001). (Pubitemid 32673521)
39. Hodis HN, Mack WJ, Zheng L et al. Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring Type 2 diabetes. Diabetes Care 29(7), 1545-1553 (2006). (Pubitemid 44127579)
40. O'Leary DH, Reuwer AQ, Nissen SN et al. Effect of rimonabant on carotid intima- media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial. Heart 97(14), 1143-1150 (2011).
41. Spence JD. The importance of distinguishing between diffuse carotid intima-media thickening and focal plaque. Can. J. Cardiol. 24, 61C-64C (2008).
42. Watanabe K, Sugiyama S, Kugiyama K et al. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J. Am. Coll. Cardiol. 46(11), 2022-2030 (2005). (Pubitemid 41713586)
43. Stein EA. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness. J. Am. Coll. Cardiol. 52(25), 2206-2209 (2008).
44. Takaya N, Yuan C, Chu BC et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events - a prospective assessment with MRI - initial results. Stroke 37(3), 818-823 (2006). (Pubitemid 43731915)
45. Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106(23), 2884-2887 (2002). (Pubitemid 35424736)
46. Corti R, Fuster V, Fayad ZA et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 46(1), 106-112 (2005). (Pubitemid 40905137)
47. Underhill HR, Yuan C, Zhao XQ et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am. Heart J. 155(3), 584 e581-e588 (2008).
48. Walker LJ, Ismail A, McMeekin W, Lambert D, Mendelow AD, Birchall D. Computed tomography angiography for the evaluation of carotid atherosclerotic plaque: correlation with histopathology of endarterectomy specimens. Stroke 33(4), 977-981 (2002). (Pubitemid 34293578)
49. Saba L, Sanfilippo R, Montisci R, Mallarini G. Carotid artery wall thickness: comparison between sonography and multi-detector row CT angiography. Neuroradiology 52(2), 75-82 (2010).
50. Saba L, Caddeo G, Sanfilippo R, Montisci R, Mallarini G. CT and ultrasound in the study of ulcerated carotid plaque compared with surgical results: potentialities and advantages of multidetector row CT angiography. AJNR Am. J. Neuroradiol. 28(6), 1061-1066 (2007). (Pubitemid 46984542)
51. Saba L, Caddeo G, Sanfilippo R, Montisci R, Mallarini G. Efficacy and sensitivity of axial scans and different reconstruction methods in the study of the ulcerated carotid plaque using multidetector-row CT angiography: comparison with surgical results. AJNR Am. J. Neuroradiol. 28(4), 716-723 (2007). (Pubitemid 46608614)
52. Saba L, Sanfilippo R, Pascalis L, Montisci R, Caddeo G, Mallarini G. Carotid artery wall thickness and ischemic symptoms: evaluation using multi-detector-row CT angiography. Eur. Radiol. 18(9), 1962-1971 (2008).
53. Spence JD, Eliasziw M, Dicicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 33(12), 2916-2922 (2002). (Pubitemid 35462866)
54. Brook RD, Bard RL, Patel S et al. Anegative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26(3), 656-662 (2006).
55. Spence JD, Coates V, Li H et al. Effects of intensive medical therapy on microemboliand cardiovascular risk in asymptomatic carotid stenosis. Arch. Neurol. (Chicago) 67(2), 180-186 (2010).
56. Spence JD, Hackam DG. Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke 41(6), 1193-1199 (2010).
57. Johnsen SH, Mathiesen EB, Joakimsen O et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø study. Stroke 38(11), 2873-2880 (2007). (Pubitemid 350035678)
58. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 36(9), 1904-1909 (2005). (Pubitemid 41266524)
59. Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G. Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis. Ultrasound Med. Biol. 35(11), 1763-1772 (2009).
60. Shai I, Spence JD, Schwarzfuchs D et al. Dietary intervention to reverse carotid atherosclerosis. Circulation 121(10), 1200-1208 (2010).
61. Kwee RM, Van Oostenbrugge RJ, Prins MH et al. Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 41(7), 1389-1393 (2010).
62. Saam T, Yuan C, Chu B et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 194(2), e34-e42 (2007). (Pubitemid 47513067)
63. Adams GJ, Greene J, Vick GW 3rd et al. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. Magn. Reson. Imaging 22(9), 1249-1258 (2004). (Pubitemid 39647723)
64. Saam T, Kerwin WS, Chu BC et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J. Cardiov. Magn. Reson. 7(5), 799-808 (2005). (Pubitemid 41770058)
65. Corti R, Fayad ZA, Fuster V et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104(3), 249-252 (2001). (Pubitemid 32666942)
66. Boussel L, Arora S, Rapp J et al. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging - multicenter trial. Radiology 252(3), 789-796 (2009).
67. Hayashi S. Significance of plasma d-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness. Int. J. Hematol. 92(1), 76-82 (2010).
68. Varghese A, Yee MS, Chan CF et al. Effect of rosiglitazone on progression of atherosclerosis: insights using 3D carotid cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 11, 24 (2009).
69. Goldberg RB, Kendall DM, Deeg MA et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with Type 2 diabetes and dyslipidemia. Diabetes Care 28(7), 1547-1554 (2005). (Pubitemid 40923063)
70. Winkelmayer WC, Setoguchi S, Levin R, Solomon DH. Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy. Arch. Intern. Med. 168(21), 2368-2375 (2008).
71. Lee JM, Robson MD, Yu LM et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J. Am. Coll. Cardiol. 54(19), 1787-1794 (2009).
72. Ayaori M, Momiyama Y, Fayad ZA et al. Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia. Atherosclerosis 196(1), 425-433 (2008).
73. Yonemura A, Momiyama Y, Fayad ZA et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J. Am. Coll. Cardiol. 45(5), 733-742 (2005). (Pubitemid 40278972)
74. Kwee RM, Truijman MT, Mess WH et al. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques. AJNR Am. J. Neuroradiol. 32(5), 950-954 (2011).
75. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 35(10), 2306-2312 (2004). (Pubitemid 39311254)
76. De Weert TT, Ouhlous M, Zondervan PE et al. In vitro characterization of atherosclerotic carotid plaque with multidetector computed tomography and histopathological correlation. Eur. Radiol. 15(9), 1906-1914 (2005). (Pubitemid 41222898)
77. Moustafa RR, Izquierdo-Garcia D, Jones PS et al. Watershed infarcts in transient ischemic attack/minor stroke with > or = 50% carotid stenosis hemodynamic or embolic? Stroke 41(7), 1410-1416 (2010).
78. Moody AR, Bitar R, Leung G, Maggisano R. Looking beyond the lumen does make all the difference. Stroke 37(7), 1648-1648 (2006).
79. Parmar JP, Rogers WJ, Mugler JP 3rd et al. Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke. Circulation 122(20), 2031-2038 (2010).
80. Singh N, Moody AR, Gladstone DJ et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 252(2), 502-508 (2009).
81. Esposito L, Saam T, Heider P et al. MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis. BMC Med. Imaging 10, 27 (2010).
82. Ouhlous M, Flach HZ, de Weert TT et al. Carotid plaque composition and cerebral infarction: MR imaging study. AJNR Am. J. Neuroradiol. 26(5), 1044-1049 (2005). (Pubitemid 43821946)
83. Underhill HR, Yuan C, Yarnykh VL et al. Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. AJNR Am. J. Neuroradiol. 31(3), 487-493 (2010).
84. Zhao XQ, Yuan C, Hatsukami TS et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler. Thromb. Vasc. Biol. 21(10), 1623-1629 (2001). (Pubitemid 34215582)
85. Zhao XQ, Phan BA, Chu B et al. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. Am. Heart J. 154(2), 239-246 (2007). (Pubitemid 47069140)
86. Dong L, Kerwin WS, Chen H et al. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum - evaluation by using dynamic contrast-enhanced MR imaging. Radiology 260(1), 224-231 (2011).
87. Young VE, Patterson AJ, Sadat U et al. Diffusion-weighted magnetic resonance imaging for the detection of lipid-rich necrotic core in carotid atheroma in vivo. Neuroradiology 52(10), 929-936 (2010).
88. Gronholdt ML, Wiebe BM, Laursen H, Nielsen TG, Schroeder TV, Sillesen H. Lipid-rich carotid artery plaques appear echolucent on ultrasound β-mode images and may be associated with intraplaque haemorrhage. Eur. J. Vasc. Endovasc. Surg. 14(6), 439-445 (1997). (Pubitemid 28051198)
89. Goncalves I, Moses J, Pedro LM et al. Echolucency of carotid plaques correlates with plaque cellularity. Eur. J. Vasc. Endovasc. Surg. 26(1), 32-38 (2003). (Pubitemid 36790159)
90. Biasi GM, Froio A, Diethrich EB et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 110(6), 756-762 (2004). (Pubitemid 39056278)
91. Prati P, Tosetto A, Casaroli M et al. Carotid plaque morphology improves stroke risk prediction: usefulness of a new ultrasonographic score. Cerebrovasc. Dis. 31(3), 300-304 (2011).
92. Kadoglou NPE, Sailer N, Moumtzouoglou A, Kapelouzou A, Gerasimidis T, Liapis CD. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J. Vasc. Surg. 51(1), 114-121 (2010).
93. Kadoglou NP, Gerasimidis T, Moumtzouoglou A et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur. J. Vasc. Endovasc. Surg. 35(6), 661-668 (2008). (Pubitemid 351680152)
94. Kadoglou NP, Gerasimidis T, Kapelouzou A et al. Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. Eur. J. Vasc. Endovasc. Surg. 39(3), 258-265 (2010).
95. Waki H, Masuyama T, Mori H et al. Ultrasonic tissue characterization of the atherosclerotic carotid artery: histological correlates or carotid integrated backscatter. Circ. J. 67(12), 1013-1016 (2003). (Pubitemid 37493709)
96. Yamada K, Yoshimura S, Kawasaki M et al. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound. Cerebrovasc. Dis. 28(4), 417-424 (2009).
97. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340(2), 115-126 (1999). (Pubitemid 29054847)
98. Kircher MF, Grimm J, Swirski FK et al. Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117(3), 388-395 (2008).
99. Wenning C, Stegger L, Hermann S, Schober O, Schäfers M. F-18-FDG imaging for atherosclerotic plaque characterization. Curr. Cardiovasc. Imaging Reports 4(3), 190-198 (2011).
100. Rudd JHF, Narula J, Strauss HW et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography. J. Am. Coll. Cardiol. 55(23), 2527-2535 (2010).
101. Ogawa M, Ishino S, Mukai T et al. (18) F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J. Nucl. Med. 45(7), 1245-1250 (2004). (Pubitemid 47611672)
102. Paulmier B, Duet M, Khayat R et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J. Nucl. Cardiol. 15(2), 209-217 (2008). (Pubitemid 351396317)
103. Rominger A, Saam T, Wolpers S et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J. Nucl. Med. 50(10), 1611-1620 (2009).
104. Grandpierre S, Desandes E, Meneroux B et al. Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case-control pilot study. Clin. Nucl. Med. 36(2), 85-90 (2011).
105. Tahara N, Kai H, Ishibashi M et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J. Am. Coll. Cardiol. 48(9), 1825-1831 (2006). (Pubitemid 44648621)
106. Tahara N, Kai H, Nakaura H et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur. Heart J. 28(18), 2243-2248 (2007). (Pubitemid 47428937)
107. Pugliese F, Gaemperli O, Kinderlerer AR et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J. Am. Coll. Cardiol. 56(8), 653-661 (2010).
108. Yuan C, Kerwin WS, Ferguson MS et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J. Magn. Reson. Imaging 15(1), 62-67 (2002). (Pubitemid 34008147)
109. Papini GD, Di Leo G, Tritella S et al. Evaluation of inflammatory status of atherosclerotic carotid plaque before thromboendarterectomy using delayed contrast-enhanced subtracted images after magnetic resonance angiography. Eur. J. Radiol. 80(3), e373-e380 (2011).
110. Papini GD, Cotticelli B, Tritella S et al. Carotid plaque contrast enhancement (CPCE) at magnetic resonance (MR) imaging: association with inflammatory cell infiltration (ICI) or cerebro- or cardio-vascular events (CCVE). Presented at: 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, USA, 28 November-3 December 2010.
111. Tang TY, Muller KH, Graves MJ et al. Iron oxide particles for atheroma imaging. Arterioscler. Thromb. Vasc. Biol. 29(7), 1001-1008 (2009).
112. Trivedi RA, Mallawarachi C, U-King-Im JM et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 26(7), 1601-1606 (2006). (Pubitemid 44288989)
113. Tang T, Howarth SP, Miller SR et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37(9), 2266-2270 (2006). (Pubitemid 44337167)
114. Tang TY, Howarth SPS, Miller SR et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J. Am. Coll. Cardiol. 53(22), 2039-2050 (2009).
115. Sigovan M, Boussel L, Sulaiman A et al. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 252(2), 401-409 (2009).
116. Mofidi R, Crotty TB, Mccarthy P, Sheehan SJ, Mehigan D, Keaveny TV. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Brit. J. Surg. 88(7), 945-950 (2001). (Pubitemid 34015576)
117. Virmani R, Kolodgie FD, Burke AP et al. Atherosclerotic plaque progression and vulnerability to rupture - angiogenesis as a source of intraplaque hemorrhage. Arterioscl Throm Vas 25(10), 2054-2061 (2005). (Pubitemid 41416300)
118. Mccarthy MJ, Loftus IM, Thompson MM et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J. Vasc. Surg. 30(2), 261-268 (1999). (Pubitemid 29395394)
119. Hiyama T, Tanaka T, Endo S et al. Angiogenesis in atherosclerotic plaque obtained from carotid endarterectomy: association between symptomatology and plaque morphology. Neurol. Med-Chir. 50(12), 1056-1061 (2010).
120. Moulton KS, Vakili K, Zurakowski D et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl Acad. Sci. USA 100(8), 4736-4741 (2003). (Pubitemid 36457799)
121. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation 113(18), 2245-2252 (2006).
122. Kyriakakis E, Cavallari M, Andert J et al. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis. Eur. J. Immunol. 40(11), 3268-3279 (2010).
123. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241(2), 459-468 (2006). (Pubitemid 44632892)
124. Kerwin W, Hooker A, Spilker M et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107(6), 851-856 (2003). (Pubitemid 36241043)
125. Tofts PS, Brix G, Buckley DL et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10(3), 223-232 (1999). (Pubitemid 29463104)
126. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn. Reson. Med. 59(3), 507-514 (2008). (Pubitemid 351348221)
127. Moguillansky D, Leng XP, Carson A et al. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur. Heart J. 32(5), 646-653 (2011).
128. Shah F, Balan P, Weinberg M et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc. Med. 12(4), 291-297 (2007).
129. Staub D, Patel MB, Tibrewala A et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 41(1), 41-47 (2010).
130. Owen DR, Shalhoub J, Miller S et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. Radiology 255(2), 638-644 (2010).
131. Magnoni M, Coli S, Marrocco-Trischitta MM et al. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur. J. Echocardiogr. 10(2), 260-264 (2009).
132. Giannoni MF, Vicenzini E. Focus on the 'unstable' carotid plaque: detection of intraplaque angiogenesis with contrast ultrasound. Present state and future perspectives. Curr. Vasc. Pharmacol. 7(2), 180-184 (2009).
133. Xiong L, Deng YB, Zhu Y, Liu YN, Bi XJ. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 251(2), 583-589 (2009).
134. Rosenkranz M, Gerloff C. Diagnostic workup in carotid stenosis - a neurologist's perspective. Neuroradiology 52(7), 619-628 (2010).
135. King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis. Stroke 40(12), 3711-3717 (2009).
136. Markus HS, King A, Shipley M et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 9(7), 663-671 (2010).
137. Young VEL, Degnan AJ, Gillard JH. Advances in contrast media for vascular imaging of atherosclerosis. Imaging Med. 3(3), 353-366 (2011).
138. Fujimoto S, Hartung D, Ohshima S et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J. Am. Coll. Cardiol. 52(23), 1847-1857 (2008).